Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Biogen
Company Monitoring Page for Biogen
latest headlines for company on cafepharma
Lecanemab can; now the wait for details begins
EP Vantage
Wed, 09/28/22 - 11:45 am
Tags:
Biogen
,
Eisai
,
lecanemab
,
clinical trials
,
Alzheimer's disease
A Biotech Breakthrough Means Big Gains for These 2 Stocks
Motley Fool
Wed, 09/28/22 - 11:02 am
Tags:
Eli Lilly
,
Biogen
,
Alzheimer's disease
,
lecanemab
,
donanemab
Biogen/Eisai Alzheimer’s treatment slowed cognitive decline in closely watched clinical trial
Stat
Wed, 09/28/22 - 12:04 am
Tags:
Biogen
,
Eisai
,
Alzheimer's disease
,
clinical trials
,
lecanemab
Biogen pays $900M to settle wide-ranging physician kickback claims
Endpoints
Tue, 09/27/22 - 10:40 am
Tags:
Biogen
,
whistleblowers
,
whistleblower lawsuits
,
legal
,
kickbacks
Biogen bolsters case for ALS drug under FDA review with new published data
MedCity News
Fri, 09/23/22 - 10:36 am
Tags:
Biogen
,
ALS
,
FDA
,
tofersen
Biogen nets $592M in Boston real estate sale as cost-cutting campaign rolls on
Fierce Pharma
Wed, 09/21/22 - 07:53 pm
Tags:
Biogen
,
Aduhelm
,
Massachusetts
,
Boston
,
real estate
,
Cambridge
Unsealed documents detail Biogen's fight against Sandoz Tysabri biosimilar
Endpoints
Tue, 09/20/22 - 08:36 pm
Tags:
Biogen
,
Novartis
,
Sandoz
,
biosimilars
,
Tysabri
,
MS
,
multiple sclerosis
Ahead of FDA filing, Sage and Biogen tout more data in hopes of alleviating durability concerns
Endpoints
Mon, 09/19/22 - 09:53 pm
Tags:
SAGE Therapeutics
,
Biogen
,
major depressive disorder
,
zuranolone
Biogen’s Antibody Lupus Treatment Shows Mid-Stage Promise
BioSpace
Fri, 09/9/22 - 11:07 am
Tags:
Biogen
,
litifilimab
,
lupus
,
systemic lupus erythematosus
,
monoclonal antibodies
,
clinical trials
Drug makers leave the pain behind
EP Vantage
Fri, 08/26/22 - 10:26 am
Tags:
painkillers
,
Acadia
,
Eli Lilly
,
Ampio Pharmaceuticals
,
Aptinyx
,
Eliem Therapeutics
,
Vertanical
,
Teva Pharamceutical
,
Regeneron
,
Vivozon
,
Vertex Pharmaceuticals
,
Biogen
Aduhelm’s loss is a win for value-based drug pricing
MedCity News
Thu, 08/11/22 - 10:39 am
Tags:
Biogen
,
Aduhelm
,
value-based pricing
,
drug pricing
,
Alzheimer's disease
Amid $1B downsizing, Biogen lists Boston-area office space for sublease
Fierce Pharma
Wed, 08/10/22 - 10:51 am
Tags:
Biogen
,
Boston
,
Cambridge MA
July Brings Layoffs, Job Creation for the Life Sciences
BioSpace
Wed, 08/3/22 - 09:32 pm
Tags:
layoffs
,
hirings
,
Astellas
,
Pfizer
,
Eikon Therapeutics
,
Bayer
,
Avadel Pharma
,
Heron Therapeutics
,
Adverum Biotechnologies
,
Biogen
,
Eisai
,
X4 Pharmaceuticals
,
Assembly Biosciences
Biogen deflects claims it misled shareholders about Aduhelm's success
Fierce Pharma
Mon, 08/1/22 - 10:27 am
Tags:
Biogen
,
Aduhelm
,
Alzheimer's disease
Biogen, watch out: Novartis' Tysabri biosim application could portend multiple sclerosis showdown in Europe and US
Fierce Pharma
Wed, 07/27/22 - 10:58 am
Tags:
Novartis
,
Biogen
,
multiple sclerosis
,
MS
,
Tysabri
,
biosimilars
FDA, in another test of its flexibility, agrees to review Biogen’s closely watched ALS drug
BioPharma Dive
Tue, 07/26/22 - 11:08 am
Tags:
Biogen
,
ALS
,
tofersen
,
FDA
Novartis asks FDA to approve biosimilar for Biogen’s top-selling MS drug
BioPharma Dive
Mon, 07/25/22 - 09:54 pm
Tags:
Novartis
,
FDA
,
Biogen
,
biosimilars
,
Tysabri
,
MS
,
multiple sclerosis
Roche, Biogen temper Alzheimer’s expectations in Q2 calls. Will Lilly follow suit in August?
Fierce Biotech
Fri, 07/22/22 - 11:21 am
Tags:
Alzheimer's disease
,
Roche
,
Biogen
,
Eli Lilly
,
lecanemab
,
gantenerumab
,
Aduhelm
For accounting purposes, Biogen says its $223M inventory of Aduhelm is basically worthless
Endpoints
Thu, 07/21/22 - 09:47 pm
Tags:
Biogen
,
Aduhelm
,
Alzheimer's disease
,
SEC
Biogen pays $900M to resolve whistleblower's MS kickback suit as competition drags on sales
Fierce Pharma
Wed, 07/20/22 - 11:17 pm
Tags:
Biogen
,
whistleblowers
,
multiple sclerosis
,
MS
,
kickbacks
Pages
« first
‹ previous
…
5
6
7
8
9
10
11
12
13
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
an umbrella protects you from: rain, sand, hunger
*
Fill in the blank.